Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022918-15Phase 3
Phase 3, randomised, double-blind trial of clindamycin + tretinoin, clindamycin and tretinoin in acne vulgaris (4 arms), sponsored by Dow Pharmaceutical Sciences. Primary endpoint: Co-primary efficacy variables.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022918-15.